The GHQ-28 questionnaire in French: a validation survey in a panel of 158 general psychiatric patients

Pariente, P; Challita, H.; Mesbah, Mounir; Guelfi, J.D.

doi:10.1017/s0924933800002455

Cited by 59 publications

(21 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It aimed at detecting those forms of psychiatric disorder which may have relevance to a patient's presence in a medical clinic, and focuses on psychological components of ill health . The GHQ is translated into Norwegian and several other languages for use in different cultural settings .…”

Section: Methodsmentioning

confidence: 99%

Psychometric properties of The Hospital Anxiety and Depression Scale and The General Health Questionnaire‐20 in COPD inpatients

Bratås

Grønning

Forbord

2013

Scandinavian Caring Sciences

View full text Add to dashboard Cite

This study demonstrates no significant differences between the HADS and GHQ-20 in their ability to detect possible cases of psychological distress in a rehabilitation setting for COPD patients. Although the HADS and GHQ-20 are measuring different concepts of psychological distress, both questionnaires can be recommended as screening tools for detection of psychological distress in COPD inpatients. The GHQ-20 appears to be two-dimensional, comprising anxiety/depression as one dimension, and coping as the other dimension.

show abstract

Section: Methodsmentioning

confidence: 99%

Psychometric properties of The Hospital Anxiety and Depression Scale and The General Health Questionnaire‐20 in COPD inpatients

Bratås

Grønning

Forbord

2013

Scandinavian Caring Sciences

View full text Add to dashboard Cite

show abstract

“…The SQ was an anonymous self-administered questionnaire speci®cally designed in order to characterize and measure NPAR related to EFV. The wording of the questions was chosen on the basis of EFV safety data in clinical trials [3±5], the Diagnostic and Statistical Manual of Mental Disorders (DSM IV) [6] and the General Health Questionnaire (GHQ-28) [7]. First, patients had to report their current antiretroviral treatment and the date of EFV initiation.…”

Section: Methodsmentioning

confidence: 99%

Long‐term assessment of neuropsychiatric adverse reactions associated with efavirenz

et al. 2003

View full text Add to dashboard Cite

The Sensio study objectives were to assess the outcome of neuropsychiatric adverse reactions (NPAR) that develop after initiation of efavirenz (EFV) therapy, to ascertain the late NPAR after a 3-month treatment period, to evaluate the impact of NPAR on patients' quality of life (QoL) in a real-life population. MethodsDuring a 6-month period, consecutive HIV-infected adult outpatients receiving an ongoing EFV therapy for at least 3 months were asked to ®ll in a speci®cally designed self-administered questionnaire addressing sleep disturbances, behavioural changes, mood disturbances, anxiety, cognitive disorders, hallucinations, dizziness and the general impact on patients' QoL. ResultsA total of 174 questionnaires were analyzed. The main late emergent NPAR were sleep disorders: abnormal dreams 24.7%, nocturnal waking 19.6%, trouble falling asleep 17.8%; cognitive disorders: memory disorders 23.0%, impaired concentration 18.9%; anxiety 15.5%; mood disorders: sadness 19.3%, suicidal ideations 9.2%. Global neuropsychic discomfort was moderate to severe in 23% of patients after a 3-month treatment period. ConclusionNPAR occur mainly during the ®rst month of EFV therapy but often persist thereafter. A signi®cant percentage of patients reported suicidal ideations at the time of the study. Our results suggest the need for routine screening for NPAR among patients receiving EFV therapy and better management. IntroductionNeuropsychiatric adverse reactions (NPAR) commonly occur within the ®rst days following initiation of treatment with efavirenz (EFV) and resolve in 2±4 weeks of EFV use [1]. NPAR have been reported in about 50% of the patients treated with this drug in clinical trials. Central nervous system disturbances range from dizziness to hallucinations, including frequent nightmares, unusual dreams and insomnia. Symptoms are usually mild to moderate [2]. The Sensio study was focused on the NPAR self-reported by HIV-positive patients with an ongoing antiretroviral regimen including EFV in real-life conditions. The objectives were to assess the outcome of NPAR that develop after initiation of EFV therapy, to ascertain the late adverse reactions of EFV after a 3-month treatment period, and to evaluate the NPAR impact on patients' quality of life (QoL). Patients and methodsDuring a 6-month period, in three HIV outpatient units, all consecutive HIV-infected adults receiving an ongoing EFV therapy for at least 3 months were concerned by the Sensio study. Capacity to understand and answer a questionnaire in the French language was required. Patients meeting these inclusion criteria were asked by investigators to complete [7]. First, patients had to report their current antiretroviral treatment and the date of EFV initiation. Then, patients assessed their own psychological and physical status by completing the following items: sleep disturbances (trouble falling asleep, nocturnal waking, early morning waking, nightmares, perturbed dreams, day-time drowsiness, fatigue) behavioural changes (euphoria, irritability, tobacco ...

show abstract

“…The SF-36 produces scores on eight subscales: general health (five items), physical functioning (10 items), limitations on usual role-related activities due to physical health problems (four items), bodily pain (two items), energy and fatigue (vitality, four items), limitations on usual role-related activities due to emotional or mental problems (three items), social functioning (two items) and emotional or mental health (five items). The GHQ-12 is a measure of psychological wellbeing or distress that is appropriate for use in general population surveys (15,16). A threshold of 2/3 was used with the GHQ-12 to indicate psychological distress requiring attention (17).…”

Section: Patients and Data Collectionmentioning

confidence: 99%

Health-related quality of life of patients with hypothalamic–pituitary–adrenal axis dysregulations: a cohort study

Bucy

Guignat

Niati

et al. 2017

European Journal of Endocrinology

View full text Add to dashboard Cite

show abstract

The GHQ-28 questionnaire in French: a validation survey in a panel of 158 general psychiatric patients

Cited by 59 publications

References 24 publications

Psychometric properties of The Hospital Anxiety and Depression Scale and The General Health Questionnaire‐20 in COPD inpatients

Psychometric properties of The Hospital Anxiety and Depression Scale and The General Health Questionnaire‐20 in COPD inpatients

Long‐term assessment of neuropsychiatric adverse reactions associated with efavirenz

Health-related quality of life of patients with hypothalamic–pituitary–adrenal axis dysregulations: a cohort study

Contact Info

Product

Resources

About